The potential impact of cannabis legalization on the development of cannabis use disorders

Preventive Medicine

Volumn 104, Issue , 2017, Pages 31-36

  Budney, Alan J ^a   Borodovsky, Jacob T ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Addiction; Cannabis; Legalization; Marijuana; Policy; Prevention; Regulation

Indexed keywords

DRONABINOL; CANNABIS;

ARTICLE; CANNABIS ADDICTION; ENVIRONMENTAL FACTOR; HEALTH BELIEF; HOSPITALIZATION; HUMAN; LIMIT OF QUANTITATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SCIENTIFIC LITERATURE; SMOKING REGULATION; SOCIAL NORM; SOCIAL STATUS; VAPING; ADDICTION; CANNABIS SMOKING; DRUG LEGISLATION; LEGISLATION AND JURISPRUDENCE; PUBLIC POLICY;

BEHAVIOR, ADDICTIVE; CANNABIS; HUMANS; LEGISLATION, DRUG; MARIJUANA ABUSE; MARIJUANA SMOKING; PUBLIC POLICY; RISK FACTORS;

EID: 85021819005     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2017.06.034     Document Type: Article

References (102)

1. Abrams, D.I., Vizoso, H.P., Shade, S.B., Jay, C., Kelly, M.E., Benowitz, N.L., Vaporization as a smokeless cannabis delivery system: a pilot study. Clin. Pharmacol. Ther. 82 (2007), 572–578.
2. Agrawal, A., Grant, J.D., Waldron, M., Duncan, A.E., Scherrer, J.F., Lynskey, M.T., Madden, P.A., Bucholz, K.K., Heath, A.C., Risk for initiation of substance use as a function of age of onset of cigarette, alcohol and cannabis use: findings in a midwestern female twin cohort. Prev. Med. 43 (2006), 125–128.
3. Agrawal, A., Madden, P.A., Martin, N.G., Lynskey, M.T., Do early experiences with cannabis vary in cigarette smokers?. Drug Alcohol Depend. 128 (2013), 255–259.
4. Anderson, P., de Bruijn, A., Angus, K., Gordon, R., Hastings, G., Impact of alcohol advertising and media exposure on adolescent alcohol use: a systematic review of longitudinal studies. Alcohol Alcohol. 44 (2009), 229–243.
5. Barry, R.A., Glantz, S., A public health framework for legalized retail marijuana based on the US experience: avoiding a new tobacco industry. PLoS Med., 13, 2016, e1002131.
6. Belendiuk, K.A., Baldini, L.L., Bonn-Miller, M.O., Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict. Sci. Clin. Pract., 10, 2015, 10.
7. Bestrashniy, J., Winters, K.C., Variability in medical marijuana laws in the United States. Psychol. Addict. Behav. 29 (2015), 639–642.
8. Bickel, W.K., DeGrandpre, R.J., Drug Policy and Human Nature. 1996, Springer, U.S.A.
9. Bickel, W.K., Johnson, M.W., Koffarnus, M.N., MacKillop, J., Murphy, J.G., The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu. Rev. Clin. Psychol. 10 (2014), 641–677.
10. Biener, L., Siegel, M., Tobacco marketing and adolescent smoking: more support for a causal inference. Am. J. Public Health 90 (2000), 407–411.
11. Borodovsky, J.T., Crosier, B.S., Lee, D.C., Sargent, J.D., Budney, A.J., Smoking, vaping, eating: is legalization impacting the way people use cannabis?. Int. J. Drug Policy 36 (2016), 141–147.
12. Borodovsky, J.T., Lee, D.C., Crosier, B.S., Gabrielli, J.L., Sargent, J.D., Budney, A.J., U.S. cannabis legalization and use of vaping and edible products among youth. Drug Alcohol Depend., 2017, 10.1016/j.drugalcdep.2017.02.017 (In press).
13. Budney, A.J., Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?. Addiction 101 (2006), 125–133.
14. Budney, A.J., Marijuana dependence and its treatment. NIDA Sci. Pract. Perspect. 4 (2007), 4–16.
15. Budney, A.J., Lile, J.A., Moving beyond the cannabis controversy into the world of the cannabinoids. Int. Rev. Psychiatry 21 (2009), 91–95.
16. Budney, A.J., Stanger, C., Tilford, J.M., Scherer, E.B., Brown, P.C., Li, Z., Li, Z., Walker, D.D., Computer-assisted behavioral therapy and contingency management for cannabis use disorder. Psychol. Addict. Behav. 29 (2015), 501–511.
17. Cantrell, J., Pearson, J.L., Anesetti-Rothermel, A., Xiao, H., Kirchner, T.R., Vallone, D., Tobacco retail outlet density and young adult tobacco initiation. Nicotine Tob. Res. 18 (2016), 130–137.
18. Carlini, B.H., Garrett, S.B., Harwick, R.M., Beyond joints and brownies: marijuana concentrates in the legal landscape of WA state. Int. J. Drug Policy 42 (2017), 26–29.
19. Caulkins, J.P., Kilmer, B., MacCoun, R.J., Pacula, R.L., Reuter, P., Design considerations for legalizing cannabis: lessons inspired by analysis of California's proposition 19. Addiction 107 (2012), 865–871.
20. Caulkins, J.P., Kilmer, B., Kleiman, M.A.R., MacCoun, R., Midgette, G., Oglesby, P., Pacula, R., Reuter, P., Options and Issues Regarding Marijuana Legalization. 2015, The RAND Corporation, Santa Monica, CA Retrieved from http://www/.rand.org/content/dam/rand/pubs/perspectives/PE100/PE149/RAND_PE149.pdf (Archived by WebCite® at http://www/.webcitation.org/6Z3moG28A).
21. Caulkins, J.P., Kilmer, B., Kleiman, M.A.R., Marijuana Legalization: What Everyone Needs to Know. 2 ed., 2016, Oxford University Press, New York.
22. Chait, L.D., Perry, J.L., Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 15 (1994), 340–349.
23. Chaloupka, F.J., Cummings, K.M., Morley, C.P., Horan, J.K., Tax, price and cigarette smoking: evidence from the tobacco documents and implications for tobacco company marketing strategies. Tob. Control. 11:Suppl. 1 (2002), I62–I72.
24. Chaloupka, F.J., Straif, K., Leon, M.E., Effectiveness of tax and price policies in tobacco control. Tob. Control. 20 (2011), 235–238.
25. Chen, C.-Y., O'Brien, M.S., Anthony, J.C., Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend. 79 (2005), 11–22.
26. Chen, C.Y., Storr, C.L., Anthony, J.C., Early-onset drug use and risk for drug dependence problems. Addict. Behav. 34 (2009), 319–322.
27. Chen, M.J., Gruenewald, P.J., Remer, L.G., Does alcohol outlet density affect youth access to alcohol?. J. Adolesc. Health 44 (2009), 582–589.
28. Colliver, J.D., Compton, W.M., Gfroerer, J.C., Condon, T., Projecting drug use among aging baby boomers in 2020. Ann. Epidemiol. 16 (2006), 257–265.
29. Colorado Department of Revenue, Licensees - Marijuana Enforcement Division. 2016.
30. Connecticut Department of Consumer Protection, Connecticut Medical Marijuana Dispensary Facilities. 2016.
31. Cook, S., Herold, K., Edidin, D.V., Briars, R., Increasing problem solving in adolescents with type 1 diabetes: the choices diabetes program. Diabetes Educ. 28 (2002), 115–124.
32. Cooper, Z.D., Haney, M., Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int. Rev. Psychiatry 21 (2009), 104–112.
33. D'Amico, E.J., Miles, J.N.V., Tucker, J.S., Gateway to curiosity: medical marijuana ads and intention and use during middle school. Psychol. Addict. Behav. 29 (2015), 613–619.
34. DeWit, David J., Adlaf, Edward M., Offord, David R., Ogborne, Alan C., Age at first alcohol use: a risk factor for the development of alcohol disorders. Am. J. Psychiatr. 157 (2000), 745–750.
35. DiFranza, J.R., Wellman, R.J., Sargent, J.D., Weitzman, M., Hipple, B.J., Winickoff, J.P., Tobacco Consortium, C.f.C.H.R.o.t.A.A.o.P, Tobacco promotion and the initiation of tobacco use: assessing the evidence for causality. Pediatrics 117 (2006), e1237–e1248.
36. D'Souza, D.C., Ranganathan, M., Medical marijuana: is the cart before the horse?. JAMA 313 (2015), 2431–2432.
37. ElSohly, M.A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., Church, J.C., Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol. Psychiatry 79 (2016), 613–619.
38. Evans, N., Farkas, A., Gilpin, E., Berry, C., Pierce, J.P., Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J. Natl. Cancer Inst. 87 (1995), 1538–1545.
39. Farrell, S., Manning, W.G., Finch, M.D., Alcohol dependence and the price of alcoholic beverages. J. Health Econ. 22 (2003), 117–147.
40. Fergusson, D.M., Horwood, L.J., Lynskey, M.T., Madden, P.A., Early reactions to cannabis predict later dependence. Arch. Gen. Psychiatry 60 (2003), 1033–1039.
41. Freisthler, B., Gruenewald, P.J., Examining the relationship between the physical availability of medical marijuana and marijuana use across fifty California cities. Drug Alcohol Depend. 143 (2014), 244–250.
42. Geiger, A., Support for Marijuana Legalization Continues to Rise. 2016, Pew Research Center.
43. Hall, W., The adverse health effects of cannabis use: what are they, and what are their implications for policy?. Int. J. Drug Policy 20 (2009), 458–466.
44. Hall, W., Lynskey, M., Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 111 (2016), 1764–1773.
45. Harper, S., Strumpf, E.C., Kaufman, J.S., Do medical marijuana laws increase marijuana use? Replication study and extension. Ann. Epidemiol. 22 (2012), 207–212.
46. Hasin, D.S., O'Brien, C.P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W.M., Crowley, T., Ling, W., et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am. J. Psychiatry 170 (2013), 834–851.
47. Hasin, D.S., Saha, T.D., Kerridge, B.T., Goldstein, R.B., Chou, S.P., Zhang, H., Jung, J., Pickering, R.P., Ruan, W.J., et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiat. 72 (2015), 1235–1242.
48. Hasin, D.S., Sarvet, A.L., Cerdá M., Keyes, K.M., Stohl, M., Galea, S., Wall, M.M., US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991–1992 to 2012–2013. JAMA Psychiat. 74 (2017), 579–588.
49. Henningfield, J.E., Benowitz, N.L., Connolly, G.N., Davis, R.M., Gray, N., Myers, M.L., Zeller, M., Reducing tobacco addiction through tobacco product regulation. Tob. Control. 13 (2004), 132–135.
50. Higgins, S.T., Heil, S.H., Lussier, J.P., Clinical implications of reinforcement as a determinant of substance use disorders. Annu. Rev. Psychol. 55 (2004), 431–461.
51. Hursh, S.R., Roma, P.G., Behavioral economics and empirical public policy. J. Exp. Anal. Behav. 99 (2013), 98–124.
52. Johnston, L.D., O'Malley, P.M., Miech, R.A., Bachman, J.G., Schulenberg, J.E., Monitoring the Future National Results on Drug Use: 1975–2014: Overview, Key Findings on Adolescent Drug Use. 2015, Institute for Social Research, The University of Michigan, Ann Arbor.
53. Keyes, K.M., Wall, M., Cerda, M., Schulenberg, J., O'Malley, P.M., Galea, S., Feng, T., Hasin, D.S., How does state marijuana policy affect US youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991–2014. Addiction 111 (2016), 2187–2195.
54. Kilmer, B., Policy designs for cannabis legalization: starting with the eight Ps. Am. J. Drug Alcohol Abuse 40 (2014), 259–261.
55. King, K.M., Chassin, L., A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence. J. Stud. Alcohol Drugs 68 (2007), 256–265.
56. Kollath-Cattano, C., Abad-Vivero, E.N., Mejia, R., Perez-Hernandez, R., Sargent, J.D., Thrasher, J.F., Portrayals of character smoking and drinking in Argentine-, Mexican- and US-produced films. Prev. Med. 90 (2016), 143–147.
57. Komro, K.A., O'Mara, R.J., Wagenaar, A.C., Perspectives from public health. Wagenaar, A.C., Burris, S., (eds.) Public Health Law Research: Theory and Methods, 1 ed., 2013, John Wiley & Sons, 49–86.
58. Kuntsche, E., Kuendig, H., Gmel, G., Alcohol outlet density, perceived availability and adolescent alcohol use: a multilevel structural equation model. J. Epidemiol. Community Health 62 (2008), 811–816.
59. Landman, A., Cortese, D.K., Glantz, S., Tobacco industry sociological programs to influence public beliefs about smoking. Soc. Sci. Med. 66 (2008), 970–981.
60. Loflin, M., Earleywine, M., A new method of cannabis ingestion: the dangers of dabs?. Addict. Behav. 39 (2014), 1430–1433.
61. Lopez-Quintero, C., Pérez de los Cobos, J., Hasin, D.S., Okuda, M., Wang, S., Grant, B.F., Blanco, C., Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 115 (2011), 120–130.
62. Lovato, C., Watts, A., Stead, L.F., Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database Syst. Rev., 2011, 10.1002/14651858.CD003439.pub2.
63. Mair, C., Freisthler, B., Ponicki, W.R., Gaidus, A., The impacts of marijuana dispensary density and neighborhood ecology on marijuana abuse and dependence. Drug Alcohol Depend. 154 (2015), 111–116.
64. McCrady, B.S., Epstein, E.E., Addictions: A Comprehensive Guidebook. Second edition, 2013, Oxford University Press, Oxford; New York.
65. Miech, R.A., Johnston, L., O'Malley, P.M., Bachman, J.G., Schulenberg, J., Patrick, M.E., Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007–2013. Int. J. Drug Policy 26 (2015), 336–344.
66. Morean, M.E., Kong, G., Camenga, D.R., Cavallo, D.A., Carroll, K.M., Pittman, B., Krishnan-Sarin, S., Contingency management improves smoking cessation treatment outcomes among highly impulsive adolescent smokers relative to cognitive behavioral therapy. Addict. Behav. 42 (2015), 86–90.
67. Mosher, J.F., Johnsson, D., Flavored alcoholic beverages: an international marketing campaign that targets youth. J. Public Health Policy 26 (2005), 326–342.
68. National Institutes of Health, Marijuana and Cannabinoids: A Neuroscience Research Summit. Marijuana and Cannabinoids: A Neuroscience Research Summit, 2016, National Institutes of Health, Bethesda, MD.
69. Pacek, L.R., Mauro, P.M., Martins, S.S., Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. Drug Alcohol Depend. 149 (2015), 232–244.
70. Pacula, R.L., Lundberg, R., Why changes in price matter when thinking about marijuana policy: a review of the literature on the elasticity of demand. Public Health Rev. 35 (2014), 1–18.
71. Pacula, R.L., Sevigny, E.L., Marijuana liberalization policies: why we can't learn much from policy still in motion. J. Policy Anal. Manage. 33 (2014), 212–221.
72. Pacula, R.L., Hunt, P., Boustead, A., Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States. J Drug Policy Anal 7 (2014), 1–19.
73. Pacula, R.L., Kilmer, B., Wagenaar, A.C., Chaloupka, F.J., Caulkins, J.P., Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am. J. Public Health 104 (2014), 1021–1028.
74. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J. Policy Anal. Manage. 34 (2015), 7–31.
75. Palamar, J.J., Ompad, D.C., Petkova, E., Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization. Int. J. Drug Policy 25 (2014), 424–435.
76. Pechmann, C., Knight, S.J., An experimental investigation of the joint effects of advertising and peers on adolescents’ beliefs and intentions about cigarette consumption. J. Consum. Res. 29 (2002), 5–19.
77. Perkonigg, A., Goodwin, R.D., Fiedler, A., Behrendt, S., Beesdo, K., Lieb, R., Wittchen, H.-U., The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 103 (2008), 439–449.
78. van der Pol, P., Liebregts, N., de Graaf, R., Korf, D.J., van den Brink, W., van Laar, M., Validation of self-reported cannabis dose and potency: an ecological study. Addiction 108 (2013), 1801–1808.
79. van der Pol, P., Liebregts, N., Brunt, T., van Amsterdam, J., de Graaf, R., Korf, D.J., van den Brink, W., van Laar, M., Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction 109 (2014), 1101–1109.
80. Printz, C., TCORS set to support the FDA's regulatory role: program designed to generate tobacco-related research to inform policy. Cancer 120 (2014), 771–772.
81. ProCon.org, 28 Legal Medical Marijuana States Plus D.C., March 31, 2017. http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881, 2017.
82. Raber, J.C., Elzinga, S., Kaplan, C., Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J. Toxicol. Sci. 40 (2015), 797–803.
83. Ramesh, D., Haney, M., Cooper, Z.D., Marijuana's dose-dependent effects in daily marijuana smokers. Exp. Clin. Psychopharmacol. 21 (2013), 287–293.
84. Reitzel, L.R., Cromley, E.K., Li, Y., Cao, Y., Dela Mater, R., Mazas, C.A., Cofta-Woerpel, L., Cinciripini, P.M., Wetter, D.W., The effect of tobacco outlet density and proximity on smoking cessation. Am. J. Public Health 101 (2011), 315–320.
85. Richter, K.P., Levy, S., Big marijuana—lessons from big tobacco. N. Engl. J. Med. 371 (2014), 399–401.
86. Rocky Mountain High Intensity Drug Trafficking Area, The Legalization of Marijuana in Colorado: The Impact. 2016.
87. Roditis, M.L., Delucchi, K., Chang, A., Halpern-Felsher, B., Perceptions of social norms and exposure to pro-marijuana messages are associated with adolescent marijuana use. Prev. Med. 93 (2016), 171–176.
88. Schmidt, L.A., Jacobs, L.M., Spetz, J., Young people's more permissive views about marijuana: local impact of state laws or national trend?. Am. J. Public Health, 2016, e1–e6.
89. Schuermeyer, J., Salomonsen-Sautel, S., Price, R.K., Balan, S., Thurstone, C., Min, S.J., Sakai, J.T., Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11. Drug Alcohol Depend. 140 (2014), 145–155.
90. Scribner, R.A., Cohen, D.A., Fisher, W., Evidence of a structural effect for alcohol outlet density: a multilevel analysis. Alcohol. Clin. Exp. Res. 24 (2000), 188–195.
91. Sevigny, E.L., Pacula, R.L., Heaton, P., The effects of medical marijuana laws on potency. Int. J. Drug Policy 25 (2014), 308–319.
92. Skinner, M.L., Haggerty, K.P., Casey-Goldstein, M., Thompson, R.W., Buddenberg, L., Mason, W.A., Focus groups of parents and teens help develop messages to prevent early marijuana use in the context of legal retail sales. Subst. Use Misuse, 2016, 1–8.
93. Swift, W., Coffey, C., Carlin, J.B., Degenhardt, L., Patton, G.C., Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction 103 (2008), 1361–1370.
94. Tashkin, D.P., Baldwin, G.C., Sarafian, T., Dubinett, S., Roth, M.D., Respiratory and immunologic consequences of marijuana smoking. J. Clin. Pharmacol. 42 (2002), 71S–81S.
95. Vandrey, R.G., Budney, A.J., Cannabis use disorders. Stolerman, I.P., Price, L.H., (eds.) Encyclopedia of Psychopharmacology, 2015, Springer-Verlag, Berlin Heidelberg, 336–341.
96. Vandrey, R., Raber, J.C., Raber, M.E., Douglass, B., Miller, C., Bonn-Miller, M.O., Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA 313 (2015), 2491–2493.
97. Vandrey, R., Herrmann, E.S., Mitchell, J.M., Bigelow, G.E., Flegel, R., LoDico, C., Cone, E.J., Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes. J. Anal. Toxicol., 2017, 1–17.
98. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R., Adverse health effects of marijuana use. N. Engl. J. Med. 370 (2014), 2219–2227.
99. Wall, M.M., Poh, E., Cerda, M., Keyes, K.M., Galea, S., Hasin, D.S., Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann. Epidemiol. 21 (2011), 714–716.
100. Weiss, S.R., Howlett, K.D., Baler, R.D., Building smart cannabis policy from the science up. Int. J. Drug Policy 42 (2017), 39–49.
101. Wen, H., Hockenberry, J.M., Cummings, J.R., The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J. Health Econ. 42 (2015), 64–80.
102. Whiting, P.F., Wolff, R.F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A.V., Keurentjes, J.C., Lang, S., Misso, K., et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313 (2015), 2456–2473.